SSGJ-612

· Shenyang Sunshine Pharmaceutical Co., LTD.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SSGJ-612, covering 2025-07-25 to 2025-07-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors [Phase 1]